FDA Import Refusal 799-4950756-1/11/1 — The Exchange Tower
The FDA refused shipment 799-4950756-1/11/1 from The Exchange Tower (Canada) on Jan 21, 2025. The refused product falls under Drugs and Biologics — INSULIN LISPRO PROTAMINE (ANTI-DIABETIC). Cited charges: 118,2060,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jan 21, 2025
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY58 INSULIN LISPRO PROTAMINE (ANTI-DIABETIC)
- Charges
- 118,2060,75